C
Christopher R. Loose
Researcher at Massachusetts Institute of Technology
Publications - 34
Citations - 1169
Christopher R. Loose is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: Progenitor cell & Stem cell. The author has an hindex of 12, co-authored 34 publications receiving 1066 citations.
Papers
More filters
Journal ArticleDOI
Controlling the release of peptide antimicrobial agents from surfaces
Anita Shukla,Kathleen E. Fleming,Helen F. Chuang,Tanguy My Chau,Christopher R. Loose,Gregory Stephanopoulos,Paula T. Hammond +6 more
TL;DR: Ponericin G1, an antimicrobial peptide known to be highly active against S. aureus, was incorporated into a hydrolytically degradable polyelectrolyte multilayer film, which provided the level of control over drug loading and release kinetics required in medically relevant applications including coatings for implant materials and bandages, while eliminating susceptibility to bacterial resistance.
Journal ArticleDOI
A linguistic model for the rational design of antimicrobial peptides
TL;DR: The rational design of new antimicrobial peptides are reported that show limited homology to naturally occurring proteins but have strong bacteriostatic activity against several species of bacteria, including Staphylococcus aureus and Bacillus anthracis.
Journal ArticleDOI
Vascular Catheters with a Nonleaching Poly-Sulfobetaine Surface Modification Reduce Thrombus Formation and Microbial Attachment
Roger S. Smith,Zheng Zhang,Michael Bouchard,Jun Li,Heather S. Lapp,Gregory R. Brotske,David L. Lucchino,Douglas Weaver,Laurence A. Roth,Arthur J. Coury,John Biggerstaff,Sivaprasad Sukavaneshvar,Robert Langer,Christopher R. Loose +13 more
TL;DR: To prevent complications over the life span of a device without using active drugs, a catheter is modified with the nonleaching polymeric sulfobetaine (polySB), which coordinates water molecules to the catheter surface, which effectively reduced protein, mammalian cell, and microbial attachment in vitro and in vivo.
Patent
Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions
TL;DR: In this article, a method for preparing and resulting articles of manufacture comprising a substrate having a surface, a bulk beneath the surface, and a grafted polymer layer on the substrate surface, in combination, constituting a modified surface having a fibrinogen adsorption of less than about 125 ng/cm2.
Patent
Layered non-fouling, antimicrobial antithrombogenic coatings
Zheng Zhang,Chad Huval,William Shannan O'shaughnessey,Michael Hencke,Trevor Squier,Jun Li,Michael Bouchard,Christopher R. Loose +7 more
TL;DR: In this article, the non-fouling, polymeric material can be grafted to a variety of functionalized substrate materials, particularly polymeric substrates and/or polymeric undercoatings immobilized on a substrate.